🔗 Share this article

Chancellor Reeves has stated she is planning "targeted steps to deal with cost of living challenges" in the upcoming Budget.

In comments to the BBC, she stated that lowering price rises is a joint responsibility of both the government and the Bank of England.

The UK's price growth is expected to be the most elevated among the G7 industrialized countries this calendar year and the following year.

Possible Energy Bill Measures

It is understood the administration could take action to bring down utility costs, for example by slashing the present 5% level of VAT applied on energy.

An additional approach is to lower some of the government charges presently included in household expenses.

Fiscal Limitations and Analyst Predictions

The government will obtain the next draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for these actions.

The view from most economists is that the Chancellor will have to declare tax rises or expenditure reductions in order to adhere to her voluntary borrowing rules.

Earlier on Thursday, estimates suggested there was a £22bn gap for the chancellor to fill, which is at the more modest range of expectations.

"There's a shared task between the Bank of England and the administration to bear down further on some of the drivers of inflation," Reeves told reporters in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and International Concerns

While a great deal of the focus has been on probable tax increases, the Treasury chief said the latest figures from the fiscal watchdog had not altered her commitment to manifesto promises not to increase rates on income tax, sales tax or National Insurance.

She attributed an "unpredictable world" with growing international and commercial concerns for the fiscal tax moves, probably to be targeted on those "wealthiest."

Global Trade Disputes

Addressing apprehensions about the UK's trade ties with China she said: "The UK's national security invariably take priority."

Last week's declaration by Chinese authorities to tighten export controls on rare earths and other resources that are essential for advanced tech production led US President the US President to propose an extra 100% tariff on goods from the Asian country, increasing the risk of an full-scale trade war between the two economic giants.

The American finance chief called China's move "commercial pressure" and "a global supply chain power grab."

Asked about considering the American proposal to join its battle with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "bad for the international commerce and generates further headwinds."

"It is my opinion there are areas where we need to address China, but there are also valuable chances to export to China's economy, including financial services and other sectors of the economic system. We've got to achieve that equilibrium correct."

The Treasury chief also confirmed she was working with G7 counterparts "on our own critical minerals strategy, so that we are reduced dependence."

Health Service Medicine Pricing and Investment

Reeves also recognized that the cost the NHS spends on drugs could rise as a result of ongoing negotiations with the Trump administration and its drugs companies, in exchange for lower tariffs and funding.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either delaying or abandoning investments in the UK, with some blaming the low prices they are obtaining.

Recently, the government science advisor said the price the health service pays for medicines would have to go up to stop companies and pharmaceutical investment departing from the United Kingdom.

The Chancellor stated to media: "We have seen because of the cost structure, that clinical trials, recent pharmaceuticals have not been provided in the UK in the extent that they are in other EU nations."

"The objective is to make sure that patients receiving treatment from the NHS are can obtain the best critical medicines in the world. And so we are reviewing all of that, and... seeking to obtain more funding into Britain."